Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

NCT03203525 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Neoplasm
Colorectal Carcinoma Metastatic in the Liver
Metastatic Malignant Neoplasm in the Liver
Refractory Malignant Neoplasm

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Pegylated Liposomal Doxorubicin Hydrochloride
DRUG: Temsirolimus
PROCEDURE: Tumor Treating Fields Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]